Gut microbiota-derived metabolites as key actors in inflammatory bowel disease
2020 · Nature Reviews Gastroenterology & Hepatology · 1,879 citations
https://doi.org/10.1038/s41575-019-0258-z
A
Aonghus Lavelle
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
3.4K
Citations
19
h-index
28
i10-index
Aonghus Lavelle is an academic researcher from Inserm. The author has contributed to research in topics: Gut microbiota and health & Inflammatory Bowel Disease & Clostridium difficile and Clostridium perfringens research. The author has an h-index of 19, co-authored 60 publications.
ORCID: 0000-0002-4461-8596Papers by this author
worksExamining the healthy human microbiome concept
2024 · Nature Reviews Microbiology · 120 citations
https://doi.org/10.1038/s41579-024-01107-0
Baseline microbiota composition modulates antibiotic-mediated effects on the gut microbiota and host
2019 · Microbiome · 79 citations
https://doi.org/10.1186/s40168-019-0725-3
Viral biogeography of the mammalian gut and parenchymal organs
2022 · Nature Microbiology · 65 citations
https://doi.org/10.1038/s41564-022-01178-w
Microbiota and body weight control: Weight watchers within?
2021 · Molecular Metabolism · 58 citations
https://doi.org/10.1016/j.molmet.2021.101427
State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus
2024 · The Lancet Microbe · 29 citations
https://doi.org/10.1016/j.lanmic.2024.07.011
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat